tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

RDHL Stock Latest News

RedHill Biopharma Initiates Phase 2 Study on Prostate Cancer Treatment
Company AnnouncementsRedHill Biopharma Initiates Phase 2 Study on Prostate Cancer Treatment
15d ago
6K
RDHL
RedHill Biopharma begins Phase 2 study of prostate cancer combination
PremiumThe Fly
RedHill Biopharma begins Phase 2 study of prostate cancer combination
15d ago
RDHL
RedHill Biopharma Engages in Strategic Market Offering to Boost Financial Flexibility
PremiumCompany Announcements
RedHill Biopharma Engages in Strategic Market Offering to Boost Financial Flexibility
16d ago
6K
RDHL
RedHill Biopharma Expands Medicare Coverage and Simplifies Talicia Dosing
PremiumCompany Announcements
RedHill Biopharma Expands Medicare Coverage and Simplifies Talicia Dosing
29d ago
6K
RDHL
RedHill Biopharma’s Talicia now covered by Humana’s Part D Plan
PremiumThe Fly
RedHill Biopharma’s Talicia now covered by Humana’s Part D Plan
29d ago
RDHL
RedHill Biopharma Advances Opaganib for GI-ARS Treatment
PremiumCompany AnnouncementsRedHill Biopharma Advances Opaganib for GI-ARS Treatment
2M ago
6K
RDHL
RedHill Biopharma’s opaganib shows radioprotective activity in study
Premium
The Fly
RedHill Biopharma’s opaganib shows radioprotective activity in study
2M ago
RDHL
RedHill Biopharma Wins $8 Million Court Judgment
Premium
Company Announcements
RedHill Biopharma Wins $8 Million Court Judgment
3M ago
6K
RDHL
RedHill Biopharma awarded judgement of approx $8M by NY Supreme Court
PremiumThe Fly
RedHill Biopharma awarded judgement of approx $8M by NY Supreme Court
3M ago
RDHL
RedHill Biopharma to Present Opaganib at U.S. Defense Conference
PremiumCompany Announcements
RedHill Biopharma to Present Opaganib at U.S. Defense Conference
4M ago
6K
RDHL
RedHill Biopharma and Duke Collaborate on Opaganib Development
PremiumCompany Announcements
RedHill Biopharma and Duke Collaborate on Opaganib Development
4M ago
6K
RDHL
RedHill Biopharma signs research pact with Duke University School of Medicine
PremiumThe Fly
RedHill Biopharma signs research pact with Duke University School of Medicine
4M ago
RDHL
RedHill Biopharma Partners with BARDA for Ebola Treatment
PremiumCompany AnnouncementsRedHill Biopharma Partners with BARDA for Ebola Treatment
4M ago
6K
RDHL
RedHill Biopharma secures federal BARDA funding for opaganib in Ebola treatment
Premium
The Fly
RedHill Biopharma secures federal BARDA funding for opaganib in Ebola treatment
4M ago
RDHL
RedHill Biopharma Secures Talicia’s Position in Medi-Cal
Premium
Company Announcements
RedHill Biopharma Secures Talicia’s Position in Medi-Cal
5M ago
6K
RDHL
RedHill Biopharma, Medi-Cal deal maintains Talicia reimbursement
PremiumThe Fly
RedHill Biopharma, Medi-Cal deal maintains Talicia reimbursement
5M ago
RDHL
RedHill Biopharma Secures Opaganib COVID-19 Patent
PremiumCompany Announcements
RedHill Biopharma Secures Opaganib COVID-19 Patent
5M ago
6K
RDHL
RedHill Biopharma announces new U.S. coronavirus patent for opaganib
PremiumThe Fly
RedHill Biopharma announces new U.S. coronavirus patent for opaganib
5M ago
RDHL
RedHill Biopharma Shareholders Approve Key Resolutions
PremiumCompany Announcements
RedHill Biopharma Shareholders Approve Key Resolutions
5M ago
6K
RDHL
RedHill Biopharma Postpones Shareholder Meeting
PremiumCompany AnnouncementsRedHill Biopharma Postpones Shareholder Meeting
5M ago
6K
RDHL
RedHill’s Talicia Advances as Preferred H. pylori Treatment
Premium
Company Announcements
RedHill’s Talicia Advances as Preferred H. pylori Treatment
5M ago
6K
RDHL
RedHill Biopharma’s Talicia listed as first-line choise for H. pylori by ACG
Premium
The Fly
RedHill Biopharma’s Talicia listed as first-line choise for H. pylori by ACG
5M ago
RDHL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >